Pines Wealth Management LLC Acquires New Shares in Sanofi (NASDAQ:SNY)

Pines Wealth Management LLC purchased a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 5,072 shares of the company's stock, valued at approximately $247,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SNY. Northwest Investment Counselors LLC bought a new position in shares of Sanofi in the third quarter valued at approximately $29,000. Concord Wealth Partners increased its holdings in Sanofi by 157.8% during the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company's stock valued at $34,000 after purchasing an additional 363 shares in the last quarter. Sunbelt Securities Inc. raised its position in Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company's stock valued at $43,000 after purchasing an additional 313 shares during the last quarter. Fortitude Family Office LLC boosted its stake in Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company's stock worth $43,000 after purchasing an additional 659 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of Sanofi by 39.2% during the third quarter. UMB Bank n.a. now owns 1,073 shares of the company's stock worth $62,000 after purchasing an additional 302 shares during the last quarter. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Sanofi from a "buy" rating to a "hold" rating in a research report on Thursday, December 12th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $57.50.

Sanofi Trading Up 2.7 %

SNY traded up $1.33 during mid-day trading on Thursday, reaching $50.70. The stock had a trading volume of 4,232,863 shares, compared to its average volume of 2,424,631. The firm's fifty day simple moving average is $48.49 and its two-hundred day simple moving average is $52.09. The stock has a market capitalization of $128.66 billion, a P/E ratio of 25.86, a P/E/G ratio of 1.17 and a beta of 0.57. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00.

Sanofi (NASDAQ:SNY - Get Free Report) last posted its quarterly earnings results on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The business had revenue of $13.44 billion for the quarter, compared to analysts' expectations of $16.59 billion. During the same quarter last year, the business earned $2.55 earnings per share. The firm's quarterly revenue was up 12.3% compared to the same quarter last year. On average, equities analysts predict that Sanofi will post 3.94 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.